TY - JOUR
T1 - Models and techniques to study aortic valve calcification in vitro, ex vivo and in vivo. An overview
AU - Bogdanova, Maria
AU - Zabirnyk, Arsenii
AU - Malashicheva, Anna
AU - Semenova, Daria
AU - Kvitting, John-Peder Escobar
AU - Kaljusto, Mari-Liis
AU - Perez, Maria Del Mar
AU - Kostareva, Anna
AU - Stensløkken, Kåre-Olav
AU - Sullivan, Gareth J.
AU - Rutkovskiy, Arkady
AU - Vaage, Jarle
N1 - Funding: This work has been funded by The South-Eastern Health Authorities by a postdoc scholarship to AR. AZ has been the recipient of a Scientia Fellow scholarship funded by the European Union and the Faculty of Medicine, University of Oslo, and has at present a postdoc scholarship from the Norwegian Health Association. Further funding has been received by the University of Oslo (including PhD scholarship to MB), The Norwegian Health Association, and by Russian Science Foundation (grant # 18-14-00152). GJS was partly supported by the Research Council of Norway through its Center of Excellence funding scheme (project number 262613).
PY - 2022/6/2
Y1 - 2022/6/2
N2 - Aortic valve stenosis secondary to aortic valve calcification is the most common valve disease in the Western world. Calcification is a result of pathological proliferation and osteogenic differentiation of resident valve interstitial cells. To develop non-surgical treatments, the molecular and cellular mechanisms of pathological calcification must be revealed. In the current overview, we present methods for evaluation of calcification in different ex vivo, in vitro and in vivo situations including imaging in patients. The latter include echocardiography, scanning with computed tomography and magnetic resonance imaging. Particular emphasis is on translational studies of calcific aortic valve stenosis with a special focus on cell culture using human primary cell cultures. Such models are widely used and suitable for screening of drugs against calcification. Animal models are presented, but there is no animal model that faithfully mimics human calcific aortic valve disease. A model of experimentally induced calcification in whole porcine aortic valve leaflets ex vivo is also included. Finally, miscellaneous methods and aspects of aortic valve calcification, such as, for instance, biomarkers are presented.
AB - Aortic valve stenosis secondary to aortic valve calcification is the most common valve disease in the Western world. Calcification is a result of pathological proliferation and osteogenic differentiation of resident valve interstitial cells. To develop non-surgical treatments, the molecular and cellular mechanisms of pathological calcification must be revealed. In the current overview, we present methods for evaluation of calcification in different ex vivo, in vitro and in vivo situations including imaging in patients. The latter include echocardiography, scanning with computed tomography and magnetic resonance imaging. Particular emphasis is on translational studies of calcific aortic valve stenosis with a special focus on cell culture using human primary cell cultures. Such models are widely used and suitable for screening of drugs against calcification. Animal models are presented, but there is no animal model that faithfully mimics human calcific aortic valve disease. A model of experimentally induced calcification in whole porcine aortic valve leaflets ex vivo is also included. Finally, miscellaneous methods and aspects of aortic valve calcification, such as, for instance, biomarkers are presented.
KW - Aortic valve
KW - Interstitial cells
KW - Endothelial cells
KW - Calcification
KW - Animal models
KW - Calcified aortic valve disease
KW - Imaging
UR - https://www.scopus.com/pages/publications/85132819696
U2 - 10.3389/fphar.2022.835825
DO - 10.3389/fphar.2022.835825
M3 - Review article
C2 - 35721220
SN - 1663-9812
VL - 13
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
M1 - 835825
ER -